Literature DB >> 16413737

Quantitative determination of puerarin in dog plasma by HPLC and study on the relative bioavailability of sustained release tablets.

Fuzheng Ren1, Qiufang Jing, Yongjia Shen, Hongmei Ma, Jingbin Cui.   

Abstract

To evaluate the bioavailability of puerarin sustained release tablet (SR-Tab.) and Yufengningxin tablet (YU-Tab.), a liquid chromatography method was developed and validated to determine puerarin in dog plasma. Chromatographic separation was performed on Diamonsil C18 column using a mixture of methanol-acetic acid-water (25:6:69, v/v/v) delivered at a flow rate of 1.0 ml/min and detected by UV. 4-Hydroxybenzaldehyde was used as the internal standard. The linear range for puerarin was from 60 to 1800 ng/ml (r=0.9991) with a limit of quantitation of 60 ng/ml. Within-day accuracy and precision ranged from -3.0 to 2.2% and from 1.2 to 4.3%, between-day accuracy and precision ranged from -4.1 to 2.6% and from 1.3 to 5.7%, respectively. The mean extraction recoveries of puerarin determined over the three concentrations were (90.3+/-5.2)%, (95.7+/-1.4)% and (93.1+/-3.5)%. A significant difference was observed in main pharmacokinetic parameters of Tmax, Cmax and AUC0-infinity between puerarin SR-Tab. and YU-Tab. in dogs. The smoother plasma concentrations were obtained from SR-Tab. in dogs and the results were as expected.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413737     DOI: 10.1016/j.jpba.2005.11.041

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Hydroxylation modification and free radical scavenging activity of puerarin-7-O-fructoside.

Authors:  Guiyou Liu; Lei Sun; Siyuan Wang; Chen Chen; Ting Guo; Yin Ji; Xuesong Li; Guodong Huang; Hua Wei; Yijun Dai; Sheng Yuan
Journal:  Folia Microbiol (Praha)       Date:  2011-08-05       Impact factor: 2.099

2.  Biotransformation of puerarin into puerarin-6″-O-phosphate by Bacillus cereus.

Authors:  Lijuan Yu; Fang Gao; Liping Yang; Lei Xu; Zhaohui Wang; Hui Ye
Journal:  J Ind Microbiol Biotechnol       Date:  2011-09-01       Impact factor: 3.346

3.  Development of an enzyme-linked immunosorbent assay to determine puerarin and its aglycone daidzein.

Authors:  Benyakarn Pongkitwitoon; Seiichi Sakamoto; Hiroyuki Tanaka; Ryota Tsuchihashi; Junei Kinjo; Satoshi Morimoto; Waraporn Putalun
Journal:  J Nat Med       Date:  2010-07-24       Impact factor: 2.343

4.  New perspectives on chinese herbal medicine (zhong-yao) research and development.

Authors:  Si-Yuan Pan; Si-Bao Chen; Hong-Guang Dong; Zhi-Ling Yu; Ji-Cui Dong; Zhi-Xian Long; Wang-Fun Fong; Yi-Fan Han; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

5.  Absolute oral bioavailability and disposition kinetics of puerarin in female rats.

Authors:  Tosapol Anukunwithaya; Pilaslak Poo; Natthaphon Hunsakunachai; Ratchanee Rodsiri; Suchinda Malaivijitnond; Phisit Khemawoot
Journal:  BMC Pharmacol Toxicol       Date:  2018-05-25       Impact factor: 2.483

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.